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ABSTRACT
The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in Norway is low, compared 
to other European and American countries. The health system includes mandatory case report-
ing and has written guidelines for prevention and control. This communication describes the na-
tional public policies related to MRSA obtained from documents and academic experience gained 
during a doctoral fellowship in Oslo, Norway. The painstaking procedures used for investigating 
suspected cases, including health professionals, decolonization and case monitoring, could be im-
portant tools to be used by countries with a high prevalence of MRSA.
Keywords: Staphylococcus aureus, resistance to methicillin, hospital infection epidemiological 
surveillance
INTRODUCTION
The prevalence rates of methicillin-resistant 
Staphylococcus aureus (MRSA) as an agent 
of nosocomial infection present relevant dif-
ferences between American and European 
countries, with rates above 40%, when com-
pared to Scandinavian countries, where the 
rates are below 1%,1 including Norway. In this 
country, the government prioritizes invest-
ments in health, education and public services. 
Cases of infection or colonization by MRSA are 
subject to mandatory reporting and severe in-
fections are uncommon.2
As part of a PhD course and studying this 
issue, we carried out a fellowship in Oslo from 
October 1, 2007 to January 31, 2008, supported 
by CAPES/ME, in the Ullevål University 
Hospital under the supervision of Prof. Dr. 
Bjorg Marit Andersen. This hospital has 1,200 
beds and 6,200 staff, and serves a population of 
150,000. Its protocol for MRSA screening and 
decolonization for both patients and health 
professionals differs in part from the national 
recommendations due to its greater rigor.3
This article aims to report both Norwe-
gian public policy and Ullevål’s institutional 
policy for the prevention and control of 
MRSA, based on official documents3,4 and our 
academic experience.
PREVENTION AND CONTROL OF MRSA
All health institutions should maintain 
preventive measures and, in accordance with 
national guidelines, follow recommendations 
for the use of antibiotics and the reporting of 
cases of MRSA. The guidelines include meas-
ures to be taken when investigating patients 
originating from outside the Netherlands or 
Scandinavia and health professionals suspect-
ed of colonization.
Measures for hospitals
Patients suspected of colonization or infection 
by MRSA are investigated and kept in isola-
tion (private room with negative pressure and 
a private bathroom). In the Ullevål Hospital, 
the following body sites are investigated, using 
a swab moistened with saline solution: the in-
ner portion and distal nasal vestibule, where 
the swab should be circled three times in each 
nostril, and the throat, including the uvula and 
both tonsils: both hands (between fingers 
and under nails) and wrists; and the genital 
region (the swab should be passed three times 
between the scrotum/vulva towards the anus). 
In the case of eczema, a wound or other inju-
ries, and drains, samples should be taken. In 
the case of catheters, the swab should be circled Este é um artigo Open Access sob
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three times around the insertion site. The guidelines recom-
mend collection of two sets, with an interval of one to two 
hours, for the nasal vestibule, the perineum, injured skin tis-
sue, pus, catheters and artificial openings.
Health professionals should wear a surgical mask, apron 
and gloves when in direct contact with suspected cases. 
Should a positive case be detected unexpectedly, patients 
and healthcare professionals who have been in contact with 
that person are also to be considered as suspected carriers. 
Infected or colonized patients, following treatment or 
decolonization, have their results monitored and receive 
written advice.
Measures for long-stay institutions
MRSA is a problem on the rise in primary care institutions 
and also in nursing homes, which are also termed “long-
term care facilities” (LTCF), for mostly being long-stay 
facilities. One concern is that, while preventive measures 
in LTCF should be the same as those recommended for 
hospitals, the former are residences where keeping MRSA 
carriers in isolation is not feasible. With this in view, experi-
ments have been carried out with the objective of altering 
behavior and procedures, in order to render viable control 
and prevention. The routine for eradication of MRSA is the 
same as those required in hospital. For persistent carriers, 
a private bathroom is recommended, although in LTCF a 
negative pressure air system is not required.
Measures for home care
The increase of MRSA carriers in the community carrying a 
specific genotype (SCCmecIV) indicates that a MRSA clone 
detected in hospitals has spread to the community, with some 
modifications. Considering the increasing possibility of public 
service users of home care (widely used in Norway) being car-
riers of MRSA, all homecare staff should wear gloves, mask and 
apron when in direct contact with patients or surfaces. The 
principles of suspicion of colonization, criteria for research 
and independence are the same as for hospitals and LTCF.5
Measures for health professionals
Health professionals who have worked in the past six months 
in the health service with a history of outbreaks of MRSA, in 
Norway or abroad, are not allowed to perform professional 
activities until the results of screening of skin lesions and 
nasal vestibule (removal of two sets with an interval of two 
hours) are known and negative. In the case of those with a 
previous history of contact with an LTCF user in a country 
where MRSA is endemic, the doctor may be able to initiate 
activities before knowing culture results.
In Ullevål Hospital, health professionals have to be 
screened on returning from holidays abroad. This procedure 
is also applied to those who have been exposed to MRSA in 
the last 12 months, or those with a previous history of coloni-
zation or infection. Until the healthcare professional has con-
firmation from the results of screening that he/she is clear of 
MRSA, when in direct contact with the patient or their care 
environment he/she should use a face mask, apron and gloves.
Positive results are reported by the laboratory directly to 
the physician and the Infection Control Office. The physician 
should inform the patient, family and health professionals 
involved in their care. He/she should also coordinate control 
measures, list patients and health grounds and communicate to 
the laboratory the number of samples required to be processed.
Colonized health professionals cannot perform activities 
in the health system and must be decolonized and the results 
followed for a period of six months. At Ullevål Hospital, sev-
en days after decolonization, three new screening cultures 
are taken at intervals of three to seven days. If the results are 
negative, MRSA is considered inactive. In the following 3, 
6, 9, and 12 months, new screenings will be carried out, and 
if all the results are negative, the professional is considered 
likely MRSA negative.
Sanitation measures for MrSa – Ullevål Hospital
The following measures are recommended for patients dur-
ing hospitalization and after discharge, and for colonized 
health professionals; they include physical decolonization 
and environmental measures in hospital, at home or in 
LTCF, to be repeated over ten days. 
It is recommended to sanitize hands between 10 and 
20 times a day with alcoholic chlorhexidine or other anti-
septic alcohol, or alternatively with tissues moistened with 
alcohol solution.
To decolonize, it is recommended to soap the body, 
while for the hair one should use chlorhexidine detergent 
for two minutes, rinse with water and then repeat the proce-
dure. Areas between fingers, perineum, navel and hair must 
be specially cleaned. 
Shower cubicle walls should be cleaned with warm 
water; the towels (separate towels for body and feet), clothes 
and nightclothes should be washed daily at a temperature 
between 65o and 85oC. Considering the frequent contami-
nation of the environment (ground, bed, door handles 
and other surfaces) daily disinfection with alcohol 70% is 
recommended.
The mouth and throat should be rinsed by gargling with 
mouthwash with chlorhexidine oral solution or hydro-
gen peroxide. The toothbrush should be rinsed in running 
water at a temperature exceeding 65oC for one to two min-
utes or immersed in chlorhexidine alcoholic solution. The 
application of mupirocin in the nasal mucosa with swabs is 
recommended, three times a day for ten days.
Personal items such as hairbrushes, sunglasses and 
contact lenses should be disinfected daily. It is recommend-
ed that one should avoid the use of soap bars, jewellery 
and makeup. Tubes and bottles should be cleaned exter-
nally and, where possible, should be of single use. 
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FINAL CONSIDERATIONS
We were able to experience the planning and imple-
mentation of MRSA prevention and control measures 
in Norway and see the rigorous adoption of epide-
miological surveillance measures. We emphasize work 
conditions, in terms of access to personal protection 
equipment and its quality and quantity, human 
resources, and also the physical infrastructure for isola-
tion. This last includes: individual rooms with private 
bathrooms, negative pressure and ideal conditions for 
hand-cleaning: the availability, inside the patient’s bath-
room, of thermal disinfection for hygiene utensils: and a 
means for the removal of contaminated materials.
Another factor is the accountability of health profes-
sionals who provide assistance, with emphasis on leadership 
and medical care, and on the adoption of measures for 
prevention and control, particularly in the investigation of 
contacts. These activities are only supervised by the Office 
of Infection Control, and are not under their responsibility.
Not all LTCF have the necessary infrastructure and 
human resources, which is perceived as one of the reasons 
for the occurrence of MRSA outbreaks and high levels of 
colonization. However, health authorities in this country 
that prioritizes the health and welfare of its citizens are 
aware of the problems that need correcting. 
We believe that the rigorous policy of identifying and 
managing cases and suspects is a key factor for the low 
prevalence of MRSA. Although it might not be possible to 
fully adopt such policies in other countries in Europe or the 
Americas, including Brazil, they could serve as inspiration 
and for reflection on the measures currently used – and on 
their disappointing results. 
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